tirzepatide by eli lilly launches weight-loss drug Mounjaro in India, beats Novo Nordisk to major market Eli Lilly, Walmart Announce Expansion

No Proceed to question 8

Losing weight while also losing strength or function is not a good long-term outcome

Why it matters: This is rare, peptides usually break down in the stomach

Circulation, 120, 982-991

The takeaway isnt that these medications should be avoided, but rather that being aware of potential cutaneous effects can help clinicians recognize medication-related skin changes quicker and manage them appropriately. For more information: Marisa Fat, BS , can be reached at [email protected].

The SURMOUNT-5 trial reported the following adverse events: Common Side Effects Most gastrointestinal side effects are mild to moderate and tend to occur during the dose escalation phase